Protein Kinase Inhibitors: all 15,766 studies that test it
Page 149 of 158. Open to participants first (2,605), then studies with results posted, then the rest; newest registration first within each.
- Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung AdenocarcinomaCompletedNCT00430261Phase 2
- A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate CancerCompletedNCT00430235Phase 2
- Effects of Imatinib Mesylate in Polycythemia VeraCompletedNCT00430066Phase 2
- Gemcitabine and Dasatinib in Advanced Solid TumorsCompletedNCT00429234Phase 1
- Effect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP)CompletedNCT00428909Phase 1
- A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast CancerCompletedNCT00428896Phase 2
- Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical CancerWithdrawnNCT00428194Phase 1
- Study Evaluating Sirolimus and Cyclosporine in Kidney Transplant RecipientsCompletedNCT00428064Phase 3
- Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath TumorsTerminatedNCT00427583Phase 2/3
- Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast CancerCompletedNCT00426530Phase 1
- Effects of Imatinib in Subjects With Seasonal Allergic Rhinitis and Who Are Sensitive to Timothy Grass PollenCompletedNCT00426179Phase 1/2
- Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent ImplantationStatus unknownNCT00426049Phase 3
- Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00425646Phase 2
- Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast CancerCompletedNCT00424164Phase 1
- Cisplatin and Everolimus in Treating Patients With Advanced Solid TumorsCompletedNCT00423865Phase 1
- Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin CancerStatus unknownNCT00423397Phase 1/2
- Effect of Food on Bioavailability of a Modified Release Formulation of ImatinibCompletedNCT00422825Phase 1
- A Study of RAD001 and Sunitinib in Metastatic Renal Cell CarcinomaCompletedNCT00422344Phase 1
- A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma PatientsCompletedNCT00421512Phase 1
- Imatinib in Adult Patients With Metastatic Ocular MelanomaTerminatedNCT00421317Phase 2
- Shift to Everolimus (RAD) Kidney Sparing StudyTerminatedNCT00420537Phase 4
- A Phase I Study of BMS-690514 in Combination With Paclitaxel and CarboplatinCompletedNCT00420186Phase 1
- Effect of Food on Bioavailability of Modified Release Formulations of ImatinibCompletedNCT00420043Phase 1
- SB-681323-Methotrexate Interaction StudyCompletedNCT00419809Phase 1
- Bioavailability Study Comparing Two New Nilotinib Tablet Formulations to an Established Nilotinib Capsule Formulation in Healthy VolunteersCompletedNCT00418769Phase 1
- Effects of Rifampin on the Pharmacokinetics of Nilotinib in Healthy SubjectsCompletedNCT00418756Phase 1
- Pharmacokinetics of Nilotinib in Subjects With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic FunctionCompletedNCT00418626Phase 1
- Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic MelanomaCompletedNCT00418496Phase 1
- Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem GliomaCompletedNCT00418327Phase 1
- Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell TumorsCompletedNCT00417807Phase 1/2
- Erlotinib in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00416650Phase 2
- Safety of AEB071 in Healthy Volunteers and to Compare the Ethnicity, Metabolic, and Safety Effects Between Caucasian and Japanese Healthy SubjectsCompletedNCT00416546Phase 1
- Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple MyelomaCompletedNCT00415064Phase 1
- Study to Assess Safety of AZD7762 Administered Alone and in Combination With Gemcitabine in Patients With Advanced Solid MalignanciesCompletedNCT00413686Phase 1
- Tamoxifen in Treatment of Acute ManiaCompletedNCT00411203Phase 3
- Gefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00411047Phase 2
- Safety Study of Rapamycin Administered Before and During Radiotherapy to Treat Rectum CancerCompletedNCT00409994Phase 1/2
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of AEB071CompletedNCT00409929Phase 1
- Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00408655Phase 1
- Efficacy of SU 011248 in Head And Neck CarcinomaTerminatedNCT00408252Phase 2
- Phase I Study of P276-00 in Patients With Advanced Refractory NeoplasmsTerminatedNCT00408018Phase 1
- Open Label Phase I Study of P276-00 in Patients With Advanced Refractory NeoplasmsCompletedNCT00407498Phase 1
- BAY-43-9006 in Advanced, Metastatic Soft Tissue SarcomasCompletedNCT00406601Phase 2
- Study Evaluating SKI-606 Administered to Healthy SubjectsCompletedNCT00406406Phase 1
- Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck CancerCompletedNCT00405405Phase 1
- Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney CancerCompletedNCT00405366Early Phase 1
- Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic CancerCompletedNCT00405210Phase 1
- A Phase II Study of MK0457 in Patients With T315I Mutant CML and Ph+All (0457-008)TerminatedNCT00405054Phase 2
- Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant PatientsCompletedNCT00403416Phase 1/2
- Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular DegenerationWithdrawnNCT00403156Phase 1
- Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant MesotheliomaCompletedNCT00402766Phase 1
- A Study of Everolimus in Combination With Imatinib in Metastatic MelanomaTerminatedNCT00402662Phase 2
- Immunosuppressive Therapy With Certican (Everolimus) After Lung TransplantationCompletedNCT00402532Phase 3
- Study of Combination of Sirolimus and Sutent in Patients With Advanced Solid Tumors Non-Curable With Standard TherapyTerminatedNCT00402415Phase 1
- A Study To Test The Effect Of GW786034 (Pazopanib) On P450 EnzymesCompletedNCT00401583Phase 1
- A Trial of Perifosine in Patients With Chemo-Insensitive SarcomasCompletedNCT00401388Phase 2
- Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic RetinopathyCompletedNCT00401115Phase 1
- Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant GliomaCompletedNCT00401024Phase 1
- Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2CompletedNCT00400374Phase 1
- A Study of R547 in Patients With Advanced Solid Tumors.CompletedNCT00400296Phase 1
- Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal CancerCompletedNCT00400114Phase 2
- A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung CancerCompletedNCT00399789Phase 1/2
- Perifosine + Sunitinib Malate for Patients With Advanced CancersCompletedNCT00399152Phase 1
- Phase I Trial of Paclitaxel With PerifosineCompletedNCT00399126Phase 1
- Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer PatientsCompletedNCT00398879Phase 2
- Phase I Study of Perifosine + Sorafenib for Patients With Advanced CancersCompletedNCT00398814Phase 1
- A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's MacroglobulinemiaCompletedNCT00398710Phase 2
- Phase I Perifosine and Gemcitabine StudyCompletedNCT00398697Phase 1
- Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple MyelomaCompletedNCT00398515Phase 1
- Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With GemcitabineCompletedNCT00397787Phase 2
- Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerCompletedNCT00397384Phase 1
- Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung CancerCompletedNCT00397293Phase 1/2
- Sirolimus Therapy for Poor Prognosis Immunoglobulin A NephropathyCompletedNCT00396721Phase 2
- A Study To Investigate The Effect Of 28 Days Of Dosing With GW856553 On Patients With Rheumatoid ArthritisCompletedNCT00393146Phase 2
- A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease)CompletedNCT00392587Phase 2
- Phase II Study of Perifosine in Patients With Refractory and Relapsed LeukemiaCompletedNCT00391560Phase 2
- AS703569 Phase I in Patients With Solid TumoursCompletedNCT00391521Phase 1
- Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL)CompletedNCT00391248Phase 2
- Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid LeukaemiaCompletedNCT00390897Phase 4
- P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic PainCompletedNCT00390845Phase 2
- Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT00390195Phase 1/2
- Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid TumorsCompletedNCT00390156Phase 1
- AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's LymphomaCompletedNCT00390117Phase 1
- Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid TumorsCompletedNCT00390000Phase 1
- Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell CarcinomaCompletedNCT00389285Phase 1/2
- Trial of Two Schedules of Perifosine for Patients With Solid Tumors or LymphomasCompletedNCT00389077Phase 2
- Glivec in Ph Positive Lymphoblastic LeukemiaCompletedNCT00388895Phase 2
- Safety Study Of Cetuximab Plus Dasatinib (BMS-354825) in Treating Advanced Solid MalignanciesCompletedNCT00388427Phase 1
- Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB)CompletedNCT00388076Phase 1
- Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant GliomaCompletedNCT00387933Phase 1
- Sunitinib in Treating Young Patients With Refractory Solid TumorsCompletedNCT00387920Phase 1
- Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma MultiformeCompletedNCT00387400Phase 1
- Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsCompletedNCT00387322Phase 1/2
- Study To Assess Long Term Safety Of PazopanibCompletedNCT00387205Phase 1
- A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.WithdrawnNCT00386555Phase 2
- Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia PatientsCompletedNCT00386373Not applicable
- Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane ChemotherapyCompletedNCT00386087Phase 2
- PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic DrugsCompletedNCT00385853Phase 1
- QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLCWithdrawnNCT00385398Phase 2
- Sorafenib and RAD001 Renal Cell CarcinomaCompletedNCT00384969Phase 1